0

Topotecan Related Compound A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATCS31043396
Molecular Weight451.47
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size25MG
1

[Topoisomerase Inhibitors Developing in Japan]

H Furue

Gan To Kagaku Ryoho. 1993 Jan;20(1):42-9.

PMID: 8422186

1

4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and Related Novel Steroid Derivatives as tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors

Thomas S Dexheimer, Lalji K Gediya, Andrew G Stephen, Iwona Weidlich, Smitha Antony, Christophe Marchand, Heidrun Interthal, Marc Nicklaus, Robert J Fisher, Vincent C Njar, Yves Pommier

J Med Chem. 2009 Nov 26;52(22):7122-31.

PMID: 19883083

1

Identification of Novel PARP Inhibitors Using a Cell-Based TDP1 Inhibitory Assay in a Quantitative High-Throughput Screening Platform

Junko Murai, Christophe Marchand, Sampada A Shahane, Hongmao Sun, Ruili Huang, Yiping Zhang, Adel Chergui, Jiuping Ji, James H Doroshow, Ajit Jadhav, Shunichi Takeda, Menghang Xia, Yves Pommier

DNA Repair (Amst). 2014 Sep;21:177-82.

PMID: 24794403

1

Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride and Paclitaxel for Second-Line or Subsequent Treatment of Advanced Ovarian Cancer: A Systematic Review and Economic Evaluation

C Main, L Bojke, S Griffin, G Norman, M Barbieri, L Mather, D Stark, S Palmer, R Riemsma

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv.

PMID: 16545208

1

Topotecan. A Review of Its Potential in Advanced Ovarian Cancer

R N Brogden, L R Wiseman

Drugs. 1998 Oct;56(4):709-23.

PMID: 9806112

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode